The FDA record for K261469 lists Barco N.V. as applicant, with a Kortrijk, Belgium filing address, product code DXJ and cardiovascular advisory committee. The submission was received on 4 May 2026 and decided on 30 September 2026 as Substantially Equivalent under a Traditional clearance path, with a summary statement. The device names on the record are Nexxis 2, Nexxis OR 2, NMS 2, MNA-240 and MNA-4x0, where the x may be any numeric character. Barco's own product documentation describes the Nexxis platform, the NMS 2 management suite and the MNA-240 decoder in more detail. [1][2][3][4]

What the FDA record covers

K261469 is the only linked FDA record in the collection reviewed for this profile, and its decision is Substantially Equivalent. The record carries product code DXJ, regulation number 870.2450 and device class 2, with the openFDA device name given as Display, Cathode-Ray Tube, Medical. The applicant address on the filing is President Kennedypark 35, Kortrijk, 8500, Belgium; that is a filing address, not a verified headquarters. [1]

The record identifies the submission as Traditional, not third-party reviewed, with the advisory committee listed as Cardiovascular and the review advisory committee as SU. A summary statement is noted. The collection counts one 510(k) record with one Substantially Equivalent decision; that count describes the linked filings reviewed, not total company sales, total portfolio or safety performance. [1]

Nexxis platform and NMS 2 software

Barco's Nexxis product page describes Nexxis as an AV-over-IP platform for the integrated digital operating room, with sharing of video and audio in and outside the OR, near-zero latency and no compression, and flexibility to meet the needs of any procedure. The page lists article number K9303090A for the Nexxis OR Management Suite. These are manufacturer-published product descriptions. [3]

The NMS 2 specification sheet describes the software as the management suite for Barco's networked visualization solution for digital operating, endoscopy and interventional rooms. It sets up, manages and monitors AV-over-IP streams between MNA encoders and decoders, and is integrated within operating room integrator user interfaces to distribute video, audio, keyboard, mouse and touch to any destination. The sheet also lists a fully featured API for integration, a Nexxis UI end-user interface, a Demonstrator web interface, a Troubleshooter web interface for device management, diagnostics and licensing, and persistent logging. [2]

MNA-240 decoder and signal path

The MNA-240 decoder specification sheet describes a 4K IP-to-AV adapter for the OR and Hybrid OR, performing AV-to-IP and IP-to-AV conversion at up to 4K resolution and labeled medical-grade. It converts RAW IP packets into DVI video plus audio and USB signals. Barco states end-to-end latency is guaranteed not to exceed a single frame, under 15 ms, and that streams distributed over the Nexxis network can reach 4K. [4]

The decoder sheet also states integration with Barco's 4K surgical products. The FDA record's device names include MNA-240 and MNA-4x0 variants, tying the decoder family to the cleared submission. Neither document establishes commercial availability, installed base or customer names. [1][4]

Applicant identity and limits of the record

Barco N.V. is the applicant named on K261469, and the manufacturer documentation is published under Barco nv copyright notices dated 2026. No parent company, brand owner or corporate group is verified in these sources, so the applicant is described only as the FDA legal applicant and the publisher of the product documentation. [1][2][4]

The sources do not state headquarters location, ownership structure, website, customer list, clinical outcomes or certifications beyond the medical-grade label on the decoder sheet. The Kortrijk address appears in the FDA filing record and should be read as filing information. Product specifications are subject to change per the manufacturer's notices. [1][2][4]